French (CAC) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jun 06, 2026

Discover French Pharmaceuticals & Biotech Growth Stocks that are on the CAC. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

48 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ALCOX	€0.37	-2.6%	65.5%	€33.0m	€1.00	2.0	139.7%	n/a
ALONC	€14.42	0%	57.3%	€99.4m	€18.64	3.0	101.2%	n/a
ALPHE	€2.00	2.6%	-53.6%	€14.4m	€5.80	4.6	78.8%	n/a
EAPI	€1.27	-14.9%	-62.7%	€120.5m	€1.76	0.2	78.3%	n/a
OSE	€3.69	-15.7%	-37.3%	€82.8m	€14.07	46.5	78.0%	n/a
DBV	€2.85	-15.1%	91.7%	€843.9m	€3.80	169.6	65.2%	n/a
ABVX	€87.85	-22.5%	1,093.6%	€7.0b	€114.77	1423.0	63.8%	n/a
GNFT	€8.77	-0.3%	135.6%	€436.7m	€14.00	6.7	61.4%	n/a
VLA	€2.34	-10.3%	-13.7%	€444.5m	€5.23	2.8	59.4%	n/a
ALTHX	€3.15	-15.8%	235.1%	€43.5m	€5.80	53.9	57.1%	n/a
NANO	€30.96	-9.0%	645.1%	€1.6b	€47.80	48.2	55.6%	n/a
ADOC	€4.28	-13.3%	23.3%	€83.9m	€13.00	21.8	55.1%	n/a
MEDCL	€26.84	-5.0%	66.3%	€963.7m	€34.76	29.7	51.2%	n/a
IPH	€1.54	-4.5%	-19.6%	€144.5m	€5.35	16.0	49.8%	n/a
IVA	€3.50	-18.3%	16.1%	€727.0m	€9.63	107.5	48.4%	n/a
ALVAL	€1.00	-13.3%	9.9%	€23.7m	€2.50	26.1	28.1%	n/a
SIGHT	€0.084	-5.4%	-58.3%	€19.6m	n/a	30.1	25.2%	n/a
ALDVI	€1.16	32.6%	-33.9%	€16.9m	€4.00	2.6	22.3%	n/a
DIM	€178.90	0.4%	-7.6%	€17.4b	€232.21	64.9	20.8%	0.4%
ERF	€64.92	3.9%	11.2%	€11.4b	€70.89	27.4	17.5%	1.1%
SAN	€77.95	3.5%	-11.8%	€93.6b	€97.10	19.4	16.9%	5.3%
MAAT	€2.86	0.4%	-48.0%	€53.9m	€10.00	11.9	14.0%	n/a
IPN	€157.80	0.8%	51.0%	€13.0b	€159.25	29.2	11.3%	0.9%
VIRP	€350.00	-2.4%	7.5%	€2.9b	€412.88	19.4	10.2%	0.4%

Page 1 of 2